Compile Data Set for Download or QSAR
Report error Found 247 Enz. Inhib. hit(s) with all data for entry = 8655
TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410826(US10383880, Example 38)
Affinity DataEC50:  11nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410874(US10383880, Example 87)
Affinity DataEC50:  20nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410827(US10383880, Example 39)
Affinity DataEC50:  21nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410907(US10383880, Example 120)
Affinity DataEC50:  23nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410959(US10383880, Example 171)
Affinity DataEC50:  25nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410931(US10383880, Example 143)
Affinity DataEC50:  28nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM50140888(CHEMBL3753839 | US10383880, Example 20)
Affinity DataEC50:  29nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410822(US10383880, Example 34)
Affinity DataEC50:  31nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410883(US10383880, Example 100 | US10383880, Example 96)
Affinity DataEC50:  32nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM50140893(CHEMBL3753932 | US10383880, Example 123)
Affinity DataEC50:  33nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410825(US10383880, Example 37)
Affinity DataEC50:  34nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM50140922(CHEMBL3752819 | US10383880, Example 57)
Affinity DataEC50:  35nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410963(US10383880, Example 175)
Affinity DataEC50:  35nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM50140889(CHEMBL3752502 | US10383880, Example 33)
Affinity DataEC50:  35nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410906(US10383880, Example 119)
Affinity DataEC50:  37nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410879(US10383880, Example 92)
Affinity DataEC50:  40nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410925(US10383880, Example 138)
Affinity DataEC50:  41nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM411033(US10383880, Example 243)
Affinity DataEC50:  42nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410899(US10383880, Example 112)
Affinity DataEC50:  44nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410973(US10383880, Example 185)
Affinity DataEC50:  45nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410873(US10383880, Example 86)
Affinity DataEC50:  46nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410888(US10383880, Example 101)
Affinity DataEC50:  50nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410908(US10383880, Example 121)
Affinity DataEC50:  51nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410971(US10383880, Example 183)
Affinity DataEC50:  53nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM411034(US10383880, Example 244)
Affinity DataEC50:  57nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM411014(US10383880, Example 224)
Affinity DataEC50:  59nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410966(US10383880, Example 178)
Affinity DataEC50:  73nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410924(US10383880, Example 137)
Affinity DataEC50:  76nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410984(US10383880, Example 194)
Affinity DataEC50:  78nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410918(US10383880, Example 131)
Affinity DataEC50:  79nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410962(US10383880, Example 174)
Affinity DataEC50:  80nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410905(US10383880, Example 118)
Affinity DataEC50:  81nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410974(US10383880, Example 186)
Affinity DataEC50:  83nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410898(US10383880, Example 111)
Affinity DataEC50:  84nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410961(US10383880, Example 173)
Affinity DataEC50:  86nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM50140765(CHEMBL1446115 | US10383880, Example 23)
Affinity DataEC50:  90nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410953(US10383880, Example 165)
Affinity DataEC50:  95nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM50140907(CHEMBL1487843 | US10383880, Example 32)
Affinity DataEC50:  100nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM50140920(CHEMBL3752323 | US10383880, Example 49)
Affinity DataEC50:  100nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM50140919(CHEMBL3753078 | US10383880, Example 46)
Affinity DataEC50:  100nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410923(US10383880, Example 136)
Affinity DataEC50:  113nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM50140904(CHEMBL3752018 | US10383880, Example 113)
Affinity DataEC50:  123nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410964(US10383880, Example 176)
Affinity DataEC50:  125nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410904(US10383880, Example 117)
Affinity DataEC50:  127nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM50140921(CHEMBL3753693 | US10383880, Example 56)
Affinity DataEC50:  128nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410954(US10383880, Example 166)
Affinity DataEC50:  147nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410976(US10383880, Example 188)
Affinity DataEC50:  147nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410837(US10383880, Example 50)
Affinity DataEC50:  148nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM410986(US10383880, Example 196)
Affinity DataEC50:  149nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandPNGBDBM50140736(CHEMBL3754710 | US10383880, Example 58)
Affinity DataEC50:  150nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

Displayed 1 to 50 (of 247 total ) | Next | Last >>
Jump to: